Here, we conducted a retrospective analysis of patients with CML‐CP who failed a first attempt at TKI discontinuation, and examined their TCR/BCR repertoires. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.